Moebius


Invest with us
Our Team
  • Moshe Weinstein CEO
  • Dr. Yaniv Dolev Founder & COO
  • Prof. Chezy Barenholz Inventor & Board Member
  • Sun Pharma & Moebius Medical Sign Exclusive Global Licensing Deal to Develop Novel Liposomal Non-opioid Pain Product for Osteoarthritis

    Sun Pharma is the world`s fifth largest specialty generic pharmaceutical company and  India`s   top pharmaceutical company

  • For more Information please visit:

    www.moebiusmedical.com
  • Moebius Medical is an innovative clinical stage biotechnology company that is developing novel pain relief treatments for osteoarthritis. 
    The company is based on a patent-protected technology that was licensed from the Hebrew University of Jerusalem, the Technion Institute and Hadassah Medical Center. The Company’s lead product, MM-II, is a patent-protected intraarticular biolubricant injection for treatment of mild to moderate symptomatic knee osteoarthritis (OA). The company has been funded by RAD Biomed, PixVine Capital – a Singapore-based early stage VC fund, and Yissum – the technology transfer company of the Hebrew University of Jerusalem.